Azithromycin tab 250 mg: Discontinuation
The supply of azithromycin 250 mg tablets has been discontinued. It will be delisted once supplies run out.
25 May 2022 update
The Apotex 250 mg tablet has been relisted for 1 June 2022 to use up the remaining stocks in the supply chain.
Why are we doing this?
Apotex is discontinuing the supply of azithromycin 250 mg tablets. We have secured an alternative brand of the 500 mg strength of azithromycin, which will remain available.
We know that there is still a need for a 250 mg tablet and we're trying to find a supplier.
October 2021: stock exhausted
We anticipate that stocks of azithromycin 250 mg tablets will be exhausted in October 2021.
1 May 2022: tablets delisted
The May 2022 delisting date allows for dispensing of residual stock within the supply chain.
1 June 2022: tablets relisted
We have been advised that there is further stocks of the 250 mg tablet in the supply chain. As such, we've relisted it temporarily.
We have secured supply of the Zithromax brand of azithromycin 500 mg tablets. Unfortunately there's no score mark on the tablet. We know that there is still a need for a 250 mg tablet and we're trying to find a supplier.
Read more detail about the ongoing supply of azithromycin tab 500 mg
Who to contact
If you have any questions, email firstname.lastname@example.org